Association of citrullinated proteins with synovial exosomes.
OBJECTIVE
In addition to releasing proteins and mediators, cells also release membrane vesicles (exosomes and apoptotic blebs) into the extracellular environment. Apoptotic blebs contain multiple autoantigens, but few data are available concerning the protein content of exosomes. Exosomes are formed during an immune response and can directly stimulate T cells or bind to dendritic cells. The aim of this study was to identify the nature of synovial exosomes from patients with different rheumatic diseases and to examine their potential autoantigenic content, which may be involved in the induction of an autoimmune response.


METHODS
Synovial exosomes from patients with rheumatoid arthritis (RA), patients with reactive arthritis, and patients with osteoarthritis were purified, analyzed by electron microscopy, and labeled with immunogold to detect IgG and IgM molecules. Autoantigen content was identified by 2-dimensional electrophoresis-immunoblotting and subsequent mass spectrometry. In order to investigate the presence of citrullinated proteins, immunoblotting with anticitrulline antibodies was performed.


RESULTS
Citrullinated proteins were observed in all exosome preparations, in contrast to other autoantigenic proteins (e.g., BiP and heterogeneous nuclear RNP A2) that were previously observed in RA and other autoimmune diseases. These citrullinated proteins included the fibrin alpha-chain fragment, fibrin beta-chain, fibrinogen beta-chain precursor, fibrinogen D fragment, and the Sp alpha (CD5 antigen-like protein) receptor. Purification of synovial exosomes led to the detection of citrullinated fibrinogen and citrullinated Sp alpha associated with IgM and IgG.


CONCLUSIONS
Synovial exosomes contain citrullinated proteins, which are known to be autoantigens in RA. Although immune mechanisms in which exosomes carry citrullinated peptides could play an important role in the induction and distribution of citrullinated proteins, there must be a specific recognition of these proteins that is unique to the RA immune system.
Skriner
K
K
Charité Universitätsmedizin Berlin, Humboldt University of Berlin, Germany. karl.skriner@charite.de
Adolph
K
K
Jungblut
P R
PR
Burmester
G R
GR
D001168:Arthritis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D016918:Arthritis, Reactive / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D001323:Autoantibodies / Q000276:immunology / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional; D005089:Exocytosis / Q000502:physiology*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D046529:Microscopy, Electron, Transmission; D010003:Osteoarthritis / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010456:Peptides, Cyclic / Q000276:immunology / Q000378:metabolism*; D013582:Synovial Fluid / Q000276:immunology / Q000378:metabolism; D013583:Synovial Membrane / Q000276:immunology / Q000378:metabolism* / Q000648:ultrastructure; D022161:Transport Vesicles / Q000276:immunology / Q000378:metabolism* / Q000648:ultrastructure
D001323:Autoantibodies; D008565:Membrane Proteins; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide